Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
Mansing Ratanasukon, Koblarp Thongthong, Patama Bhurayanontachai, Pichai JirarattanasopaDepartment of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Hat yai, Songkhla Province, ThailandBackground: To evaluate photoreceptor disruption in patients with central serous chorioretinopat...
Guardado en:
Autores principales: | Ratanasukon M, Thongthong K, Bhurayanontachai P, Jirarattanasopa P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec3b1c3cfe3c4fdd8d2340eb9d5cffd1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak T, et al.
Publicado: (2015) -
Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
por: Fujita K, et al.
Publicado: (2012) -
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin Z, et al.
Publicado: (2014) -
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
por: Yu-Chen Hu, et al.
Publicado: (2021) -
Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy
por: Tsakonas GD, et al.
Publicado: (2012)